0001209191-23-004237.txt : 20230120
0001209191-23-004237.hdr.sgml : 20230120
20230120161433
ACCESSION NUMBER: 0001209191-23-004237
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230119
FILED AS OF DATE: 20230120
DATE AS OF CHANGE: 20230120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MENDLEIN JOHN
CENTRAL INDEX KEY: 0001238362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36076
FILM NUMBER: 23541146
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 651311552
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-19
0
0001434316
FATE THERAPEUTICS INC
FATE
0001238362
MENDLEIN JOHN
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE
SAN DIEGO
CA
92131
1
0
0
0
Common Stock
2023-01-19
4
M
0
28461
1.37
A
311231
D
Stock Option (Right to Buy)
1.37
2023-01-19
4
M
0
28461
0.00
A
2023-02-06
Common Stock
28461
0
D
This stock option is fully vested and exercisable.
/s/ Cindy Tahl, as Attorney-in-Fact
2023-01-20